Fig. 4From: Synergistic effect of BCL2 and FLT3 co-inhibition in acute myeloid leukemiaAdoptive transfer AML murine model from Tet2−/−Flt3ITD mice treated with venetoclax and FLT3i. a Study design. b Disease progression was monitored by bimonthly flow cytometry of CD45.2 + (donor) cells. c Spleens were excised and measured at the end of the study. d Spleens were weighed at the end of the studyBack to article page